Tag Archives: championed

FibroGen founder Thomas Neff dies suddenly as drug he championed racks up milestones

After founding FibroGen in 1993 and leading the company for 26 years, chairman and CEO Thomas B. Neff passed away over the weekend unexpectedly. His death comes as FibroGen nears the critical U.S. and European filings for its Astellas- and AstraZeneca-partnered oral anemia med roxadustat, which recently won its second approval in China.  Thomas Neff With Neff’s… Read More »